BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 30390110)

  • 21. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.
    Guo M; Hu L; Baliga M; He Z; Hughson MD
    Am J Clin Pathol; 2004 Dec; 122(6):894-901. PubMed ID: 15539381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of continued upregulation of p16(INK4a) through the evolution from high-grade squamous intraepithelial lesion to invasive squamous carcinoma of the cervix.
    Cheah PL; Looi LM; Mun KS; Abdoul Rahman N; Teoh KH
    Malays J Pathol; 2011 Dec; 33(2):83-7. PubMed ID: 22299207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
    Lee SJ; Lee AW; Kang CS; Park JS; Park DC; Ki EY; Lee KH; Yoon JH; Hur SY; Kim TJ
    Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of p16 and HPV L1 capsid proteins as predictive markers in cervical lesions.
    Izadi-Mood N; Sarmadi S; Eftekhar Z; Jahanteegh HA; Sanii S
    Arch Gynecol Obstet; 2014 Jun; 289(6):1287-92. PubMed ID: 24346122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology.
    Shin EK; Lee SR; Kim MK; Kang EJ; Ju W; Lee SN; Han WS; Kim SC
    Diagn Cytopathol; 2008 May; 36(5):311-6. PubMed ID: 18418881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
    Tsoumpou I; Valasoulis G; Founta C; Kyrgiou M; Nasioutziki M; Daponte A; Koliopoulos G; Malamou-Mitsi V; Karakitsos P; Paraskevaidis E
    Gynecol Oncol; 2011 Apr; 121(1):49-53. PubMed ID: 21194734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
    Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
    Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.
    Yemelyanova A; Gravitt PE; Ronnett BM; Rositch AF; Ogurtsova A; Seidman J; Roden RB
    Mod Pathol; 2013 Feb; 26(2):268-74. PubMed ID: 22996373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
    Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
    Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens.
    Yu L; Wang L; Zhong J; Chen S
    Cancer Cytopathol; 2010 Feb; 118(1):47-55. PubMed ID: 20069634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
    Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J
    Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Clinical Significance of HPV L1/PD-L1 Tests Combined with Colposcopy for Cervical Precancerous Lesions and Cervical Cancer].
    Luo GP; Zeng X; Cao HY; Tang D; Xi MR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):516-522. PubMed ID: 34018374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.
    Negri G; Bellisano G; Zannoni GF; Rivasi F; Kasal A; Vittadello F; Antoniazzi S; Faa G; Ambu R; Egarter-Vigl E
    Am J Surg Pathol; 2008 Nov; 32(11):1715-20. PubMed ID: 18769337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
    Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating clinical outcome of HPV induced cervical lesions by combination of capsid protein L1 and p16INK4a protein detection.
    Bolanca IK; Sentija K; Simon SK; Kukura V; Vranes J
    Coll Antropol; 2010 Mar; 34(1):31-6. PubMed ID: 20432730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
    Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
    Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
    Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
    Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.